TransMedics Group, Inc.

NasdaqGM:TMDX 株式レポート

時価総額:US$5.0b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

TransMedics Group 過去の業績

過去 基準チェック /26

TransMedics Groupは、平均年間9.6%の収益成長を遂げていますが、 Medical Equipment業界の収益は、年間 成長しています。収益は、平均年間8.1% 60.5%収益成長率で 成長しています。 TransMedics Groupの自己資本利益率は1.6%であり、純利益率は0.8%です。

主要情報

9.6%

収益成長率

46.7%

EPS成長率

Medical Equipment 業界の成長8.9%
収益成長率60.5%
株主資本利益率1.6%
ネット・マージン0.8%
前回の決算情報30 Jun 2024

最近の業績更新

Recent updates

TransMedics Group: Providing Long-Term Detailed Forecast And Upgrading To Buy

Aug 04

TransMedics Group, Inc. Just Recorded A 66% EPS Beat: Here's What Analysts Are Forecasting Next

Aug 02
TransMedics Group, Inc. Just Recorded A 66% EPS Beat: Here's What Analysts Are Forecasting Next

TransMedics Group Stock: Too Far, Too Fast

Jul 08

TransMedics: NOP, Logistics And Transport Are Key Growth Drivers But Stock Is Pricey

Jun 17

TransMedics Group (NASDAQ:TMDX) Might Have The Makings Of A Multi-Bagger

Jun 10
TransMedics Group (NASDAQ:TMDX) Might Have The Makings Of A Multi-Bagger

TransMedics: Transportation Supporting Growth

May 21

TransMedics Group: Looking At The Road Ahead After An Exceptional Q1 (Rating Downgrade)

May 06

TransMedics Group, Inc. (NASDAQ:TMDX) Stocks Shoot Up 27% But Its P/S Still Looks Reasonable

Apr 24
TransMedics Group, Inc. (NASDAQ:TMDX) Stocks Shoot Up 27% But Its P/S Still Looks Reasonable

TransMedics Group: Founder Led Company With Solid Potential

Apr 19

Is TransMedics Group (NASDAQ:TMDX) Using Too Much Debt?

Apr 11
Is TransMedics Group (NASDAQ:TMDX) Using Too Much Debt?

TransMedics Group: Emerging Medical Device Market Leader With A Long Growth Runway

Mar 19

TransMedics Group: Huge Opportunity In Organ Transplants

Mar 12

TransMedics: A Very Expensive Growth Stock

Feb 07

With TransMedics Group, Inc. (NASDAQ:TMDX) It Looks Like You'll Get What You Pay For

Jan 23
With TransMedics Group, Inc. (NASDAQ:TMDX) It Looks Like You'll Get What You Pay For

Calculating The Fair Value Of TransMedics Group, Inc. (NASDAQ:TMDX)

Jan 02
Calculating The Fair Value Of TransMedics Group, Inc. (NASDAQ:TMDX)

Does TransMedics Group (NASDAQ:TMDX) Have A Healthy Balance Sheet?

Nov 05
Does TransMedics Group (NASDAQ:TMDX) Have A Healthy Balance Sheet?

This Just In: Analysts Are Boosting Their TransMedics Group, Inc. (NASDAQ:TMDX) Outlook for This Year

Aug 06
This Just In: Analysts Are Boosting Their TransMedics Group, Inc. (NASDAQ:TMDX) Outlook for This Year

TransMedics Group (NASDAQ:TMDX) Has Debt But No Earnings; Should You Worry?

Aug 02
TransMedics Group (NASDAQ:TMDX) Has Debt But No Earnings; Should You Worry?

TransMedics Group, Inc. (NASDAQ:TMDX) Not Lagging Industry On Growth Or Pricing

Jun 29
TransMedics Group, Inc. (NASDAQ:TMDX) Not Lagging Industry On Growth Or Pricing

Brokers Are Upgrading Their Views On TransMedics Group, Inc. (NASDAQ:TMDX) With These New Forecasts

May 06
Brokers Are Upgrading Their Views On TransMedics Group, Inc. (NASDAQ:TMDX) With These New Forecasts

Is TransMedics Group (NASDAQ:TMDX) Using Too Much Debt?

Apr 27
Is TransMedics Group (NASDAQ:TMDX) Using Too Much Debt?

Estimating The Intrinsic Value Of TransMedics Group, Inc. (NASDAQ:TMDX)

Apr 09
Estimating The Intrinsic Value Of TransMedics Group, Inc. (NASDAQ:TMDX)

Is TransMedics Group (NASDAQ:TMDX) A Risky Investment?

Jan 16
Is TransMedics Group (NASDAQ:TMDX) A Risky Investment?

TransMedics: Game Changer Technology Will Boost Revenue Growth

Oct 20

収支内訳

TransMedics Group の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。


収益と収入の歴史

NasdaqGM:TMDX 収益、費用、利益 ( )USD Millions
日付収益収益G+A経費研究開発費
30 Jun 24359314247
31 Mar 24297-1012942
31 Dec 23242-2511836
30 Sep 23192-3610731
30 Jun 23151-189327
31 Mar 23119-288125
31 Dec 2293-367027
30 Sep 2272-426027
30 Jun 2251-485426
31 Mar 2239-474525
31 Dec 2130-443822
30 Sep 2128-383221
30 Jun 2130-302820
31 Mar 2125-282417
31 Dec 2026-292419
30 Sep 2024-322421
30 Jun 2024-352521
31 Mar 2026-362622
28 Dec 1924-342420
28 Sep 1921-322217
29 Jun 1918-291815
30 Mar 1915-261514
29 Dec 1813-241214
29 Sep 1812-211014
30 Jun 189-20914
31 Mar 188-20814
30 Dec 178-21815
31 Dec 166-24816

質の高い収益: TMDX 非現金収入 のレベルが高いです。

利益率の向上: TMDX過去に利益を上げました。


フリー・キャッシュフローと収益の比較


過去の収益成長分析

収益動向: TMDX過去 5 年間で収益を上げており、収益は年間9.6%増加しています。

成長の加速: TMDXは昨年収益を上げたため、収益成長率を 5 年間の平均と比較することは困難です。

収益対業界: TMDX昨年収益を上げたため、昨年の収益成長をMedical Equipment業界 ( 5.5% ) と比較することは困難です。


株主資本利益率

高いROE: TMDXの 自己資本利益率 ( 1.6% ) は 低い とみなされます。


総資産利益率


使用総資本利益率


過去の好業績企業の発掘